Researchers at Children's Hospital of Philadelphia (CHOP) unveiled a novel antibody-drug conjugate (ADC) that shows striking ...

In this video, Joshua Brody, MD, discusses primary analysis results from LOTIS-7 and SUNMO trials, both of which are investigating combination therapies for diffuse large B-cell lymphoma.“These two ...

A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), ...

Merck has shared positive results from the Phase II IDeate-Lung01 trial (NCT05280470) evaluating ifinatamab deruxtecan (I-DXd) in patients with previously treated extensive-stage small cell lung ...

A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in ...

In an otherwise treatment-refractory population, the combination shows favorable overall response rates in patients with ...